What does Theratrame do?
THERATRAME specializes in the development of innovative therapeutic solutions aimed at improving patient outcomes. The company focuses on advanced drug delivery systems and targeted therapies to enhance the effectiveness of medical treatments. With a commitment to research and development, THERATRAME seeks to address unmet medical needs across various therapeutic areas.
- Activities
- Signals
-
Reporting lossesReporting losses € -2.12M
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -1.12MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -1.62MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 1.75MStrong equity provides a buffer against setbacks.
Low riskLow risk 65.8%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.49A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Healthy social debtHealthy social debt 11.2%Social debts stay manageable relative to personnel costs.
- Shareholders
- Société Régionale D'investissement De Wallonie 12,59%, Wallonie Entreprendre 12,59%, Qbic Iii Fund 12,59%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|
|
€
-869K
|
€
7K
|
€
-383K
|
|
|
€
-1.62M
|
€
-488K
|
€
-546K
|
|
|
€
-2.12M
|
€
-1.07M
|
€
-1.12M
|
|
|
€
1.75M
|
€
775K
|
€
1.85M
|
|
|
65.76%
|
34.96%
|
74.73%
|
|
|
€
913K
|
€
1.44M
|
€
625K
|
|
|
€
1.56M
|
€
1.12M
|
€
1.16M
|
|
|
10.60
|
8.50
|
4
|
Publications 7
All publications- Statuts (Traduction, Coordination, Autres Modifications, ?) - Capital, Actions - Demissions, Nominations 29/05/2026
- Capital, Actions 22/12/2025
- Statuts (Traduction, Coordination, Autres Modifications, ?) - Divers - Capital, Actions 23/10/2025
- Demissions, Nominations 09/07/2025
- Demissions, Nominations 23/04/2024
Frequently asked questions
Answers to the most common questions about Theratrame, based on official government data and the filed annual accounts.
What is the VAT number of Theratrame?
The VAT number of Theratrame is BE0786.448.581.
How many employees work at Theratrame?
In 2025, Theratrame employed 10.60 full-time equivalents (FTE).
When was Theratrame established?
Theratrame was founded in 23-05-2022.
What is the official address of Theratrame?
The official address of Theratrame is Avenue De L'hôpital 1 Liège 4000.
What is the legal form of Theratrame?
The juridical form of Theratrame is Public limited company (NV/SA).
What is the annual revenue of Theratrame?
The 2025 accounts of Theratrame do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Theratrame do?
THERATRAME specializes in the development of innovative therapeutic solutions aimed at improving patient outcomes. The company focuses on advanced drug delivery systems and targeted therapies to enhance the effectiveness of medical treatments. With a commitment to research and development, THERATRAME seeks to address unmet medical needs across various therapeutic areas.
Is Theratrame a reliable company?
Theratrame is a registered Rechtspersoon with company number 0786.448.581 and can be verified through the official CBE database.
What is the credit limit of Theratrame?
The estimated credit limit of Theratrame is €85,480.
Is Theratrame still active?
Theratrame currently has the status "Normal situation" and is active.